These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 19450979)
1. Antiviral effect of ribonuclease conjugated oligodeoxynucleotides targeting the IRES RNA of the hepatitis C virus. Gamble C; Trotard M; Le Seyec J; Abreu-Guerniou V; Gernigon N; Berrée F; Carboni B; Felden B; Gillet R Bioorg Med Chem Lett; 2009 Jul; 19(13):3581-5. PubMed ID: 19450979 [TBL] [Abstract][Full Text] [Related]
2. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment. Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754 [TBL] [Abstract][Full Text] [Related]
3. Roles of the polypyrimidine tract and 3' noncoding region of hepatitis C virus RNA in the internal ribosome entry site-mediated translation. Wang H; Shen XT; Ye R; Lan SY; Xiang L; Yuan ZH Arch Virol; 2005 Jun; 150(6):1085-99. PubMed ID: 15747050 [TBL] [Abstract][Full Text] [Related]
4. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation. Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496 [TBL] [Abstract][Full Text] [Related]
5. Human ribosomal protein L18a interacts with hepatitis C virus internal ribosome entry site. Dhar D; Mapa K; Pudi R; Srinivasan P; Bodhinathan K; Das S Arch Virol; 2006 Mar; 151(3):509-24. PubMed ID: 16195786 [TBL] [Abstract][Full Text] [Related]
6. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation. Pudi R; Ramamurthy SS; Das S J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945 [TBL] [Abstract][Full Text] [Related]
7. A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IV-targeted aptamer inhibits translation by binding to an apical loop of domain IIId. Kikuchi K; Umehara T; Fukuda K; Kuno A; Hasegawa T; Nishikawa S Nucleic Acids Res; 2005; 33(2):683-92. PubMed ID: 15681618 [TBL] [Abstract][Full Text] [Related]
8. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro. Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270 [TBL] [Abstract][Full Text] [Related]
9. The hepatitis C virus internal ribosome-entry site: a new target for antiviral research. Gallego J; Varani G Biochem Soc Trans; 2002 Apr; 30(2):140-5. PubMed ID: 12023841 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis C IRES: translating translation into a therapeutic target. Jubin R Curr Opin Mol Ther; 2001 Jun; 3(3):278-87. PubMed ID: 11497352 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C viral protein translation: mechanisms and implications in developing antivirals. Hoffman B; Liu Q Liver Int; 2011 Nov; 31(10):1449-67. PubMed ID: 21745290 [TBL] [Abstract][Full Text] [Related]
12. An engineered inhibitor RNA that efficiently interferes with hepatitis C virus translation and replication. Romero-López C; Berzal-Herranz B; Gómez J; Berzal-Herranz A Antiviral Res; 2012 May; 94(2):131-8. PubMed ID: 22426470 [TBL] [Abstract][Full Text] [Related]
13. Interfering with hepatitis C virus IRES activity using RNA molecules identified by a novel in vitro selection method. Romero-López C; Barroso-delJesus A; Puerta-Fernández E; Berzal-Herranz A Biol Chem; 2005 Feb; 386(2):183-90. PubMed ID: 15843163 [TBL] [Abstract][Full Text] [Related]
14. [Structure and function of the non-coding regions of hepatitis C viral RNA]. Dutkiewicz M; Swiqtkowska A; Ciesiołka J Postepy Biochem; 2006; 52(1):62-71. PubMed ID: 16869303 [TBL] [Abstract][Full Text] [Related]
15. hnRNP L is required for the translation mediated by HCV IRES. Hwang B; Lim JH; Hahm B; Jang SK; Lee SW Biochem Biophys Res Commun; 2009 Jan; 378(3):584-8. PubMed ID: 19061868 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of hepatitis C virus IRES-mediated translation by oligonucleotides. Li X; Mueller S; Wimmer E Virus Res; 2009 Dec; 146(1-2):29-35. PubMed ID: 19720092 [TBL] [Abstract][Full Text] [Related]
17. Translational insensitivity to potent activation of PKR by HCV IRES RNA. Shimoike T; McKenna SA; Lindhout DA; Puglisi JD Antiviral Res; 2009 Sep; 83(3):228-37. PubMed ID: 19467267 [TBL] [Abstract][Full Text] [Related]
18. A chimeric GB virus B with 5' nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins. Rijnbrand R; Yang Y; Beales L; Bodola F; Goettge K; Cohen L; Lanford RE; Lemon SM; Martin A Hepatology; 2005 May; 41(5):986-94. PubMed ID: 15793797 [TBL] [Abstract][Full Text] [Related]
19. RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA. Paek KY; Kim CS; Park SM; Kim JH; Jang SK J Virol; 2008 Dec; 82(24):12082-93. PubMed ID: 18842733 [TBL] [Abstract][Full Text] [Related]
20. [The construction and evaluation of antisense RNA expression vector targeting at HCV 5'NCR]. Wang XH; Wang SQ; Guan W; Mao BZ Sheng Wu Gong Cheng Xue Bao; 2001 Mar; 17(2):179-82. PubMed ID: 11411227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]